Stephan Kloeß

1.9k total citations
24 papers, 1.2k citations indexed

About

Stephan Kloeß is a scholar working on Immunology, Oncology and Hematology. According to data from OpenAlex, Stephan Kloeß has authored 24 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Immunology, 15 papers in Oncology and 6 papers in Hematology. Recurrent topics in Stephan Kloeß's work include Immune Cell Function and Interaction (20 papers), CAR-T cell therapy research (14 papers) and T-cell and B-cell Immunology (12 papers). Stephan Kloeß is often cited by papers focused on Immune Cell Function and Interaction (20 papers), CAR-T cell therapy research (14 papers) and T-cell and B-cell Immunology (12 papers). Stephan Kloeß collaborates with scholars based in Germany, United States and Switzerland. Stephan Kloeß's co-authors include Ulrike Koehl, Ruth Esser, Axel Schambach, Winfried S. Wels, Lubomir Arseniev, Julia D. Suerth, Olaf Oberschmidt, Christoph Priesner, Thomas Klingebiel and Wolfgang Glienke and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Frontiers in Immunology.

In The Last Decade

Stephan Kloeß

24 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephan Kloeß Germany 16 931 879 196 153 127 24 1.2k
Srinivas S. Somanchi United States 15 1.1k 1.2× 880 1.0× 195 1.0× 224 1.5× 102 0.8× 30 1.3k
Paul W. Eldridge United States 14 750 0.8× 627 0.7× 361 1.8× 235 1.5× 173 1.4× 23 1.1k
Patrick Schlegel Germany 17 498 0.5× 529 0.6× 329 1.7× 200 1.3× 102 0.8× 44 1.1k
Andrea M. Sheehan United States 11 376 0.4× 581 0.7× 74 0.4× 251 1.6× 123 1.0× 23 919
Meng‐Fen Wu United States 11 581 0.6× 948 1.1× 47 0.2× 164 1.1× 251 2.0× 16 1.1k
Bartosz Grzywacz United States 14 960 1.0× 597 0.7× 266 1.4× 204 1.3× 38 0.3× 31 1.2k
Justyna Ogonek Germany 11 404 0.4× 504 0.6× 263 1.3× 214 1.4× 122 1.0× 14 945
Premal Lulla United States 17 290 0.3× 702 0.8× 139 0.7× 258 1.7× 231 1.8× 64 938
Dirk M. van der Steen Netherlands 14 432 0.5× 440 0.5× 109 0.6× 283 1.8× 145 1.1× 28 747
Vicky Torrano United States 6 389 0.4× 791 0.9× 75 0.4× 181 1.2× 187 1.5× 9 893

Countries citing papers authored by Stephan Kloeß

Since Specialization
Citations

This map shows the geographic impact of Stephan Kloeß's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephan Kloeß with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephan Kloeß more than expected).

Fields of papers citing papers by Stephan Kloeß

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephan Kloeß. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephan Kloeß. The network helps show where Stephan Kloeß may publish in the future.

Co-authorship network of co-authors of Stephan Kloeß

This figure shows the co-authorship network connecting the top 25 collaborators of Stephan Kloeß. A scholar is included among the top collaborators of Stephan Kloeß based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephan Kloeß. Stephan Kloeß is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zimmermann, Katharina, Doris Steinemann, Stephan Kloeß, et al.. (2023). CAR-NK Cells Targeting HER1 (EGFR) Show Efficient Anti-Tumor Activity against Head and Neck Squamous Cell Carcinoma (HNSCC). Cancers. 15(12). 3169–3169. 13 indexed citations
2.
Kloeß, Stephan, Olaf Oberschmidt, Arnold Kloos, et al.. (2019). Preclinical Assessment of Suitable Natural Killer Cell Sources for Chimeric Antigen Receptor Natural Killer–Based “Off-the-Shelf” Acute Myeloid Leukemia Immunotherapies. Human Gene Therapy. 30(4). 381–401. 44 indexed citations
3.
Oberschmidt, Olaf, Michael Morgan, Volker Huppert, et al.. (2019). Development of Automated Separation, Expansion, and Quality Control Protocols for Clinical-Scale Manufacturing of Primary Human NK Cells and Alpharetroviral Chimeric Antigen Receptor Engineering. Human Gene Therapy Methods. 30(3). 102–120. 55 indexed citations
4.
Kloeß, Stephan, et al.. (2019). CAR-Expressing Natural Killer Cells for Cancer Retargeting. Transfusion Medicine and Hemotherapy. 46(1). 4–13. 61 indexed citations
5.
Oberschmidt, Olaf, Stephan Kloeß, & Ulrike Koehl. (2017). Redirected Primary Human Chimeric Antigen Receptor Natural Killer Cells As an “Off-the-Shelf Immunotherapy” for Improvement in Cancer Treatment. Frontiers in Immunology. 8. 654–654. 52 indexed citations
6.
Shatnyeva, Olga, Katrin S. Reiners, Samir Tawadros, et al.. (2016). Mono- and dual-targeting triplebodies activate natural killer cells and have anti-tumor activityin vitroandin vivoagainst chronic lymphocytic leukemia. OncoImmunology. 5(9). e1211220–e1211220. 18 indexed citations
7.
Kloeß, Stephan, Nariman Ansari, Ernst H. K. Stelzer, et al.. (2015). Cytotoxicity and infiltration of human NK cells in in vivo-like tumor spheroids. BMC Cancer. 15(1). 351–351. 75 indexed citations
8.
Suerth, Julia D., Michael Morgan, Stephan Kloeß, et al.. (2015). Efficient generation of gene-modified human natural killer cells via alpharetroviral vectors. Journal of Molecular Medicine. 94(1). 83–93. 69 indexed citations
9.
Glienke, Wolfgang, Ruth Esser, Christoph Priesner, et al.. (2015). Advantages and applications of CAR-expressing natural killer cells. Frontiers in Pharmacology. 6. 21–21. 200 indexed citations
10.
Sundarasetty, Bala Sai, Stephan Kloeß, Olaf Oberschmidt, et al.. (2015). Generation of lentivirus-induced dendritic cells under GMP-compliant conditions for adaptive immune reconstitution against cytomegalovirus after stem cell transplantation. Journal of Translational Medicine. 13(1). 240–240. 13 indexed citations
11.
Elze, Markus C., Oana Ciocârlie, Stephan Kloeß, et al.. (2014). Dendritic cell reconstitution is associated with relapse-free survival and acute GVHD severity in children after allogeneic stem cell transplantation. Bone Marrow Transplantation. 50(2). 266–273. 13 indexed citations
12.
Tischer, Sabine, Christoph Priesner, Hans‐Gert Heuft, et al.. (2014). Rapid generation of clinical-grade antiviral T cells: selection of suitable T-cell donors and GMP-compliant manufacturing of antiviral T cells. Journal of Translational Medicine. 12(1). 336–336. 38 indexed citations
13.
Brehm, Claudia, Sabine Huenecke, Ruth Esser, et al.. (2014). Interleukin-2-stimulated natural killer cells are less susceptible to mycophenolate mofetil than non-activated NK cells: possible consequences for immunotherapy. Cancer Immunology Immunotherapy. 63(8). 821–833. 27 indexed citations
14.
Berghuis, Dagmar, Marco W. Schilham, Susy J. Santos, et al.. (2012). Histone deacetylase inhibitors enhance expression of NKG2D ligands in Ewing sarcoma and sensitize for natural killer cell-mediated cytolysis. SHILAP Revista de lepidopterología. 2(1). 8–8. 60 indexed citations
15.
Brehm, Claudia, Sabine Huenecke, Andrea Quaiser, et al.. (2011). IL-2 Stimulated but Not Unstimulated NK Cells Induce Selective Disappearance of Peripheral Blood Cells: Concomitant Results to a Phase I/II Study. PLoS ONE. 6(11). e27351–e27351. 71 indexed citations
16.
Esser, Ruth, Tina Müller, Stephan Kloeß, et al.. (2011). NK cells engineered to express a GD2‐specific antigen receptor display built‐in ADCC‐like activity against tumour cells of neuroectodermal origin. Journal of Cellular and Molecular Medicine. 16(3). 569–581. 166 indexed citations
17.
Huenecke, Sabine, Stefanie Zimmermann, Stephan Kloeß, et al.. (2010). IL-2−driven Regulation of NK Cell Receptors With Regard to the Distribution of CD16+ and CD16− Subpopulations and In Vivo Influence After Haploidentical NK Cell Infusion. Journal of Immunotherapy. 33(2). 200–210. 77 indexed citations
18.
Kloeß, Stephan, Sabine Huenecke, Ruth Esser, et al.. (2010). IL‐2‐activated haploidentical NK cells restore NKG2D‐mediated NK‐cell cytotoxicity in neuroblastoma patients by scavenging of plasma MICA. European Journal of Immunology. 40(11). 3255–3267. 72 indexed citations
19.
Schubert, Ralf, Janine Reichenbach, Stephan Kloeß, et al.. (2010). Reactive Oxygen Species Abrogate the Anticarcinogenic Effect of Eicosapentaenoic Acid in Atm-Deficient Mice. Nutrition and Cancer. 62(5). 584–592. 4 indexed citations
20.
Koehl, Ulrike, Stephan Kloeß, Stefanie Zimmermann, et al.. (2008). Cytotoxic effects of treosulfan and busulfan against leukemic cells of pediatric patients. Cancer Chemotherapy and Pharmacology. 62(5). 821–830. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026